The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

We expect the company to post a mid-single-digit uptick in revenue, driven by higher FreeStyle Libre sales. Our interactive dashboard analysis of Abbott’s FY 2024Q3 Earnings Preview has more ...

Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor.

The shift towards glucose-sensing technology has heralded a new era in diabetes management, moving from occasional, reactive ...

For individuals living with Type 2 diabetes, managing blood sugar levels can feel like walking a tightrope. The delicate balance between medication, diet and lifestyle often leaves many feeling ...

IRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes ...

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio in the U.S., expanding patient choice and streamlining diabetes care workflows. Tidepool ...